Terumo BCT is a medical technology company that offers products, software, and services for blood and cell collection and preparation to treat challenging diseases and conditions. Their target market includes blood centers, hospitals, therapeutic apheresis clinics, cell collection and processing organizations, researchers, and private medical practices. Terumo BCT has developed technologies such as the Quantum Flex platform for rapid expansion of CAR-T cells and the Reveos Automated Whole Blood Processing System. It is a subsidiary of Terumo Corporation and is focused on improving access to treatment and reducing health inequities, with a particular focus on sickle cell disease and cell therapy manufacturing solutions.
Headquarters
Ul. Hutnicza 14
Katowice; Slaskie;
Postal Code: 40-241
Contact Details: Purchase the Terumo Bct Polska Sp. z o.o. report to view the information.
Website: http://www.terumobct.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service